Using whole-transcriptome sequencing, we found the depletion of RBM7 contributed to exon exclusion in approximately 70% SE/A5E events, implying RBM7 mainly functions as a splicing activator in the context of SE/A5E in breast cancer. The gene discussed is RBM7; the disease is breast cancer.